619
Views
17
CrossRef citations to date
0
Altmetric
Case Reports

Successful rituximab treatment of refractory hemophagocytic lymphohistiocytosis and autoimmune hemolytic anemia associated with systemic lupus erythematosus

, , , , &
Pages 855-857 | Received 30 Oct 2012, Accepted 17 Jan 2013, Published online: 11 Feb 2014

References

  • Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48: 124–131
  • Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003;49: 633–639
  • Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008;47: 1686–1691
  • Kim JM, Kwok SK, Ju JH, Kim HY, Park SH. Reactive hemophagocytic syndrome in adult Korean patients with systemic lupus erythematosus: a case-control study and literature review. J Rheumatol. 2012;39: 86–93
  • Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine. 2006;85: 169–182
  • Keeling DM, Isenberg DA. Haematological manifestations of systemic lupus erythematosus. Blood Rev. 1993;7: 199–207
  • Giannouli S, Voulgarelis M, Ziakas PD, Tzioufas AG. Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment. Ann Rheum Dis. 2006;65: 144–148
  • Gomard-Mennesson E, Ruivard M, Koenig M, Woods A, Magy N, Ninet J et al. Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases. Lupus. 2006;15: 223–231
  • Coon WW. Splenectomy for cytopenias associated with systemic lupus erythematosus. Am J Surg. 1988;155: 391–394
  • Smith KG, Jones RB, Burns SM, Jayne DR. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum. 2006;54: 2970–2982
  • Lee JW, Kim HA, Sung JM, Suh CH. Successful treatment of refractory immune thrombocytopenia with anti-CD20 antibody in a patient with systemic lupus erythematosus. Lupus. 2010;19: 227–228
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40: 1725
  • Szyper-Kravitz M. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm. Isr Med Assoc J. 2009;11: 633–634.
  • Takahashi N, Naniwa T, Banno S. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol. 2008;18: 72–75
  • Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology (Oxford). 2007;46: 1621–1622
  • Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Quart J Med. 1991;80: 605–612.
  • Jacob HS. Pulse steroids in hematologic diseases. Hosp Pract (Off Ed). 1985;20: 87–94.
  • Corley CC Jr, Lessner HE, Larsen WE. Azathioprine therapy of “autoimmune” diseases. Am J Med. 1966;41: 404–412
  • Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol. 1976;13: 323–334.
  • Letchumanan P, Thumboo J. Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review. Semin Arthritis Rheum. 2011;40: 298–306
  • Alba P, Karim MY, Hunt BJ. Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome. Lupus. 2003;12: 633–635
  • Garcia-Carrasco M, Jimenez-Hernandez M, Escarcega RO, Mendoza C, Galarza-Maldonado C, Sandoval-Cruz M et al. Use of rituximab in patients with systemic lupus erythematosus: an update. Autoimmun Rev. 2009;8: 343–348
  • Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2007;29: 569–573
  • Xu XJ, Tang YM, Song H, Yang SL, Xu WQ, Zhao N et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160(984–90): e1
  • Kamiya K, Kurasawa K, Arai S, Maezawa R, Hanaoka R, Kumano K et al. Rituximab was effective on refractory thrombotic thrombocytopenic purpura but induced a flare of hemophagocytic syndrome in a patient with systemic lupus erythematosus. Mod Rheumatol. 2010;20: 81–85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.